Gut microbiota and its metabolites in diabetic kidney disease: underlying mechanisms and recent research breakthroughs
Year: 2026
Type: article
Abstract: Diabetic kidney disease (DKD) stands as a paramount microvascular complication of diabetes, now recognized globally as the primary driver of end-stage renal disease. Recent years have witnessed intensive scrutiny into how gut microbiota, operating through the “gut–kidney axis,” orchestrate the onset and advancement of DKD. Patients with DKD manifest a bidirectional dysbiosis: a depletion of beneficial short-chain fatty acid (SCFA)-producing bacteria coincides with an enrichment of pathogenic or opportunistic strains. This microbial imbalance precipitates a dual crisis—insufficient production of protective metabolites like butyrate alongside the accumulation of gut-derived uremic toxins such as indoxyl sulfate (IS), p-cresyl sulfate (pCS), and trimethylamine N-oxide (TMAO). Acting in concert, these metabolites fuel renal inflammation, oxidative stress, and fibrosis by activating diverse signaling cascades, including TLR4/NF-κB and NLRP3 inflammasome. Emerging intervention strategies aimed at modulating the gut microbiota—ranging from dietary adjustments and probiotics/prebiotics to fecal microbiota transplantation and natural products—have demonstrated promise in retarding DKD progression. This review synthesizes current insights into the mechanisms and research trajectories linking gut microbiota and their metabolites to DKD, striving to establish a robust theoretical foundation for clinical translation.
Authors: Yuan Yuan(Conceptualization, Data curation, Investigation, Visualization, Writing – original draft), XinXin Pang(Conceptualization, Funding acquisition, Supervision, Writing – original draft), Yachan Gao(Conceptualization, Data curation, Investigation, Visualization, Writing – original draft), Yanan Wang(Data curation, Investigation, Writing – original draft), ChaoYang Du(Methodology, Writing – original draft), ZhiHang Qiao(Data curation, Validation, Writing – original draft), Rui Cheng(Investigation, Validation, Writing – original draft)
Institution: Henan University of Chinese Medicine
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: diabetic nephropathy, gut microbiota, gut-kidney axis, short-chain fatty acids, butyrate, uremic toxins, indoxyl sulfate, p-cresyl sulfate, trimethylamine N-oxide, renal inflammation, oxidative stress, renal fibrosis, TLR4/NF-κB signaling, NLRP3 inflammasome, dysbiosis, probiotics, prebiotics, fecal microbiota transplantation, dietary intervention, natural products
Open Access status: gold
Estimated APC paid: $3,801
Award: G9001379988
OpenAlex ID: W7233778612
